RNA Translated 2021, “RNA Therapeutics”
In 2021, the first mRNA vaccines against COVID-19 received FDA approval. Based on decades of RNA research, these vaccines are only the beginning of the RNA therapeutic research breakthroughs. Our 2021 issue of RNA Translated presents 18 interviews with U-M scientists and scholars whose research contributes to RNA therapeutics. The magazine particularly focuses on three domains of RNA therapeutics: mRNA vaccines, ASOs and CRISPR. The second part of the publication highlights our main activities for the period from July 1, 2020 through June 30, 2021.
